Haleon plc (LON:HLN) Insider Dawn Allen Sells 74,679 Shares of Stock

Haleon plc (LON:HLN) insider Dawn Allen sold 74,679 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.66), for a total transaction of £277,805.88 ($348,258.59).

Haleon Trading Up 2.1 %

Shares of HLN stock opened at GBX 380.30 ($4.77) on Friday. The stock has a 50-day moving average of GBX 379.39 and a 200-day moving average of GBX 357.09. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 54.18. The stock has a market cap of £34.38 billion, a price-to-earnings ratio of 3,164.33, a PEG ratio of 1.49 and a beta of 0.19. Haleon plc has a 1-year low of GBX 308.37 ($3.87) and a 1-year high of GBX 400.65 ($5.02).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank lifted their price target on shares of Haleon from GBX 410 ($5.14) to GBX 447 ($5.60) and gave the stock a “buy” rating in a report on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.